Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update
Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for ...
Verona Pharma stock soars to all-time high of $62.09
Verona Pharma PLC (NASDAQ:VRNA) shares have reached an all-time high, touching a price level of $62.09. According to ...
Canaccord raises Verona Pharma target to $72; maintains buy
Canaccord Genuity maintained a Buy rating on Verona Pharma (NASDAQ:VRNA) while significantly increasing the price target to $72.00 from the previous $44.00. According to InvestingPro data, analyst ...
Verona Pharma price target raised to $72 from $44 at Canaccord
Canaccord raised the firm’s price target on Verona Pharma (VRNA) to $72 from $44 and keeps a Buy rating on the shares. The firm believes the ...